The Cooper Companies, Inc. (NASDAQ:COO) Stock Holdings Lowered by Simplify Asset Management Inc.

Simplify Asset Management Inc. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 56.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,868 shares of the medical device company's stock after selling 11,470 shares during the quarter. Simplify Asset Management Inc.'s holdings in Cooper Companies were worth $978,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quent Capital LLC increased its position in shares of Cooper Companies by 300.0% during the first quarter. Quent Capital LLC now owns 828 shares of the medical device company's stock worth $84,000 after acquiring an additional 621 shares during the period. Empowered Funds LLC purchased a new position in Cooper Companies in the first quarter valued at $256,000. QRG Capital Management Inc. purchased a new position in Cooper Companies in the first quarter valued at $481,000. US Bancorp DE increased its holdings in Cooper Companies by 255.3% in the first quarter. US Bancorp DE now owns 49,895 shares of the medical device company's stock valued at $5,062,000 after buying an additional 35,850 shares during the last quarter. Finally, ProShare Advisors LLC increased its holdings in Cooper Companies by 291.2% in the first quarter. ProShare Advisors LLC now owns 26,818 shares of the medical device company's stock valued at $2,721,000 after buying an additional 19,963 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Down 0.2 %

NASDAQ COO traded down $0.23 during mid-day trading on Friday, reaching $99.63. 1,415,083 shares of the stock were exchanged, compared to its average volume of 1,126,768. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38. The business's fifty day simple moving average is $106.83 and its 200 day simple moving average is $97.93. The stock has a market capitalization of $19.84 billion, a PE ratio of 55.50, a PEG ratio of 2.20 and a beta of 0.99. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies's revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $0.84 EPS. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. StockNews.com upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Thursday. Robert W. Baird upped their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the company an "outperform" rating in a research note on Thursday, August 29th. Morgan Stanley increased their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an "equal weight" rating in a research note on Tuesday, September 10th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Thursday, August 29th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $117.00.

Insider Activity at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares of the company's stock, valued at $18,267,624.69. The trade was a 41.03 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is currently owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.